Samantha McLemore — Patient Capital ManagementSuperinvestor
About Samantha McLemore — Patient Capital Management’s 13F portfolio
Samantha McLemore — Patient Capital Management is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Samantha McLemore — Patient Capital Management reported $3.0B across 39 US-listed positions (). Its largest position is ROYALTY PHARMA PLC (RPRX) at 6.7% of the reported book, and its ten biggest holdings make up 52% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: RPRX ROYALTY PHARMA PLC | $67.72 −1.38% | 6.7% | 3.6M | $201.8M |
| 2 | NYSE: C CITIGROUP INC | $115.28 −1.76% | 6.5% | 1.4M | $196.4M |
| 3 | NASDAQ: GOOGL ALPHABET INC | $272.66 −3.46% | 6.2% | 526K | $187.9M |
| 4 | NYSE: UNH UNITEDHEALTH GROUP INC | $330.48 −5.55% | 6.0% | 438K | $182.0M |
| 5 | NASDAQ: AMZN AMAZON COM INC | $257.37 −3.87% | 5.4% | 681K | $162.3M |
| 6 | NASDAQ: NVDA NVIDIA CORPORATION | $145.98 −3.30% | 4.7% | 710K | $142.0M |
| 7 | NYSE: CVS CVS HEALTH CORP | $80.04 −1.61% | 4.2% | 1.2M | $127.8M |
| 8 | NYSE: NCLH NORWEGIAN CRUISE LINE HLDGS | $17.07 −5.11% | 4.2% | 6.0M | $127.3M |
| 9 | NYSE: QXO QXO INC | $11.02 −2.04% | 4.1% | 7.1M | $123.3M |
| 10 | NYSE: ET ENERGY TRANSFER L P | $19.11 +0.42% | 3.9% | 6.1M | $116.3M |
| 11 | NASDAQ: IAC PEOPLE INC | $44.54 −4.21% | 3.7% | 2.4M | $112.0M |
| 12 | NASDAQ: PGEN PRECIGEN INC | $4.16 −2.58% | 3.6% | 19.0M | $108.5M |
| 13 | NASDAQ: UAL UNITED AIRLS HLDGS INC | $105.53 −1.95% | 3.3% | 732K | $99.5M |
| 14 | NASDAQ: CROX CROCS INC | $157.31 −3.35% | 3.2% | 799K | $96.4M |
| 15 | NASDAQ: META META PLATFORMS INC | $596.22 −3.27% | 3.2% | 171K | $96.2M |
| 16 | NASDAQ: CHYM CHIME FINL INC | $30.85 −4.25% | 2.8% | 4.1M | $83.6M |
| 17 | NASDAQ: ADBE ADOBE INC | $221.68 −2.00% | 2.5% | 361K | $74.0M |
| 18 | NYSE: SDRL SEADRILL LTD | $39.82 −3.54% | 2.5% | 2.0M | $73.9M |
| 19 | NYSE: GPN GLOBAL PMTS INC | $83.52 −2.45% | 2.3% | 942K | $68.4M |
| 20 | NASDAQ: COIN COINBASE GLOBAL INC | $108.87 −1.48% | 2.2% | 462K | $67.5M |
| 21 | Cboe BZX: FBTC FIDELITY WISE ORIGIN BITCOIN | $53.90 −0.83% | 2.1% | 1.2M | $62.2M |
| 22 | NASDAQ: BIIB BIOGEN INC | $247.13 −1.70% | 2.0% | 284K | $61.3M |
| 23 | NASDAQ: ILMN ILLUMINA INC | $200.66 −4.45% | 2.0% | 345K | $60.7M |
| 24 | NYSE: GM GENERAL MTRS CO | $81.75 −0.46% | 1.6% | 632K | $48.7M |
| 25 | NYSE: UBS UBS GROUP AG | $45.02 −1.38% | 1.6% | 954K | $47.3M |
Showing 1–25 of 39 positions on this page reported in this 13F.
- Healthcare25%
- Consumer Cyclical17%
- Communication Services13%
- Financial Services13%
- Technology12%
- Industrials11%
- Energy6.5%
- AddedUNHUNITEDHEALTH GROUP INC+0.1%$182.0M
- AddedAMZNAMAZON COM INC+4.1%$162.3M
- AddedNCLHNORWEGIAN CRUISE LINE HLDGS+4.9%$127.3M
- AddedQXOQXO INC+5.3%$123.3M
- AddedPGENPRECIGEN INC+6.8%$108.5M
- AddedCHYMCHIME FINL INC+41.7%$83.6M
- AddedADBEADOBE INC+21.5%$74.0M
- NewGPNGLOBAL PMTS INC—$68.4M
- AddedCOINCOINBASE GLOBAL INC+7.3%$67.5M
- AddedFBTCFIDELITY WISE ORIGIN BITCOIN+244%$62.2M
- ReducedRPRXROYALTY PHARMA PLC−1.2%$201.8M
- ReducedCCITIGROUP INC−0.7%$196.4M
- ReducedGOOGLALPHABET INC−1.5%$187.9M
- ReducedNVDANVIDIA CORPORATION−0.2%$142.0M
- ReducedCVSCVS HEALTH CORP−9.0%$127.8M
- ReducedETENERGY TRANSFER L P−0.1%$116.3M
- ReducedIACPEOPLE INC−10.2%$112.0M
- ReducedUALUNITED AIRLS HLDGS INC−0.1%$99.5M
- ReducedCROXCROCS INC−5.2%$96.4M
- ReducedMETAMETA PLATFORMS INC−0.2%$96.2M
Reading Samantha McLemore — Patient Capital Management’s 13F portfolio
Samantha McLemore — Patient Capital Management’s $3.0B 13F book is spread across 39 reported positions and is concentrated toward its biggest ideas, with the top ten holdings at 52%. The largest positions carry real weight, so how those names perform matters a lot to the overall book. Its five largest positions are RPRX, C, GOOGL, UNH and AMZN, led by ROYALTY PHARMA PLC (RPRX) at 6.7% of the portfolio. The heaviest sector exposure is Healthcare (25%), then Consumer Cyclical (17%).
What Samantha McLemore — Patient Capital Management changed last quarter
Between 2026-03-31 and Q2 2026, Samantha McLemore — Patient Capital Management was a net seller: it opened 2 new positions and added to 11 more, while trimming 24 and closing 1 outright. Against a 39-name book, that is moderate turnover, pointing to steady rotation within the portfolio. Its largest new or increased position was UNITEDHEALTH GROUP INC (UNH), and its biggest reduction was ROYALTY PHARMA PLC (RPRX).
What a 13F does and doesn’t reveal
A 13F captures only Samantha McLemore — Patient Capital Management’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Samantha McLemore — Patient Capital Management is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Samantha McLemore — Patient Capital Management's profile on this page is built directly from those filings.
How current is the 13F data on Samantha McLemore — Patient Capital Management's page?
It reflects Samantha McLemore — Patient Capital Management's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Samantha McLemore — Patient Capital Management files its next quarterly report, this page refreshes automatically.
Can I see Samantha McLemore — Patient Capital Management's complete list of holdings?
This page highlights Samantha McLemore — Patient Capital Management's largest positions rather than all 39 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Samantha McLemore — Patient Capital Management's filings.
Does a 13F show everything Samantha McLemore — Patient Capital Management owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Samantha McLemore — Patient Capital Management's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Samantha McLemore — Patient Capital Management made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

